Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Badve

Showing results (51-60 of 206) with videos related to

Pageof 21
Sort By:
Carcinogenesis|September 26, 2007
Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnoverNagendra K Prasad, Manish Tandon, Sunil Badve, et al.
Nature Reviews. Clinical Oncology|February 11, 2025
Artificial intelligence in digital pathology - time for a reality checkArpit Aggarwal, Satvika Bharadwaj, Germán Corredor, et al.
Lancet (London, England)|September 19, 2003
A Mexican man with "too much blood"Montaser Shaheen, Klaus A Hilgarth, Donald Hawes, et al.
Journal of Surgical Oncology|January 24, 2007
Benign glandular inclusions a rare cause of a false positive sentinel nodeLaura E Norton, Ian K Komenaka, Robert E Emerson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 1, 2009
Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scoresFoluso O Ademuyiwa, Mangesh A Thorat, Rohit K Jain, et al.
Scientific Reports|August 29, 2013
Identification of FDA-approved drugs targeting breast cancer stem cells along with biomarkers of sensitivityPoornima Bhat-Nakshatri, Chirayu P Goswami, Sunil Badve, et al.
Scientific Reports|March 6, 2015
Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancersYesim Gökmen-Polar, I Tudor Vladislav, Yaseswini Neelamraju, et al.
Cancer Biology & Therapy|July 7, 2010
ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancerHitesh Appaiah, Poornima Bhat-Nakshatri, Rutika Mehta, et al.
Cancer Research|May 20, 2016
Molecular Insights of Pathways Resulting from Two Common PIK3CA Mutations in Breast CancerPoornima Bhat-Nakshatri, Chirayu P Goswami, Sunil Badve, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2013
The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 casesI Tudor Vladislav, Yesim Gökmen-Polar, Kenneth A Kesler, et al.
Pageof 21

Showing results (51-60 of 206) with videos related to

Sort By:
Pageof 21
Carcinogenesis|September 26, 2007
Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnoverNagendra K Prasad, Manish Tandon, Sunil Badve, et al.
Nature Reviews. Clinical Oncology|February 11, 2025
Artificial intelligence in digital pathology - time for a reality checkArpit Aggarwal, Satvika Bharadwaj, Germán Corredor, et al.
Lancet (London, England)|September 19, 2003
A Mexican man with "too much blood"Montaser Shaheen, Klaus A Hilgarth, Donald Hawes, et al.
Journal of Surgical Oncology|January 24, 2007
Benign glandular inclusions a rare cause of a false positive sentinel nodeLaura E Norton, Ian K Komenaka, Robert E Emerson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 1, 2009
Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scoresFoluso O Ademuyiwa, Mangesh A Thorat, Rohit K Jain, et al.
Scientific Reports|August 29, 2013
Identification of FDA-approved drugs targeting breast cancer stem cells along with biomarkers of sensitivityPoornima Bhat-Nakshatri, Chirayu P Goswami, Sunil Badve, et al.
Scientific Reports|March 6, 2015
Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancersYesim Gökmen-Polar, I Tudor Vladislav, Yaseswini Neelamraju, et al.
Cancer Biology & Therapy|July 7, 2010
ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancerHitesh Appaiah, Poornima Bhat-Nakshatri, Rutika Mehta, et al.
Cancer Research|May 20, 2016
Molecular Insights of Pathways Resulting from Two Common PIK3CA Mutations in Breast CancerPoornima Bhat-Nakshatri, Chirayu P Goswami, Sunil Badve, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2013
The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 casesI Tudor Vladislav, Yesim Gökmen-Polar, Kenneth A Kesler, et al.
Pageof 21